Our commitment to transforming renal care is focused on working with you to achieve better outcomes for your patients as they sequence through their therapy journey; supporting the highest standards and access to care.
Chronic kidney disease (CKD) is an urgent and growing global challenge. We estimate there are as many as 4 million end-stage renal disease (ESRD) patients globally, and millions more people go undiagnosed; this is a situation projected to grow annually. While your patient population is growing, your time and cost resources are not increasing. We understand you need meaningful innovations and services that help you deliver better outcomes for more patients.
For more than 60 years, we have partnered with the nephrology community to focus on pioneering care in both hemodialysis (HD) and peritoneal dialysis (PD); and we maintain that pioneering spirit today through new therapies like expanded hemodialysis (HDx) and remote patient management.
Advancing Global Renal Care
Leading innovation with the SHARESOURCE Remote Patient Management platform.
SHARESOURCE extends your reach by allowing visibility to your home patients’ adherence patterns, which may allow earlier intervention. The telehealth platform is the only globally available two-way technology that allows you to remotely monitor and manage therapy from your clinic, which includes the ability to change a patient’s prescription setting remotely. Patients using an automated PD system with SHARESOURCE are less likely to drop out of therapy1, and they experience a reduced number of hospitalizations1. Likewise, healthcare providers are reporting a statistically significant increase in preemptive patient consults and APD prescription adjustments2-3, as well as reduced resource utilization and associated cost4. SHARESOURCE is featured with our AMIA APD System and HOMECHOICE CLARIA APD System.
AMIA with SHARESOURCE for Renal Care
AMIA automated peritoneal dialysis (APD) with the SHARESOURCE remote patient management platform is the first and only APD system to include user-friendly features that help guide end-stage renal disease patients through home peritoneal dialysis (PD) therapy, while keeping them remotely connected with their healthcare providers.
The AMIA Automated Peritoneal Dialysis system is available in the United States and Canada.
HDx Enabled by THERANOVA for Renal Care
HDx enabled by THERANOVA is a new dialysis therapy we are pioneering for patients with end-stage renal disease. The THERANOVA dialyzer features an innovative membrane, which provides an expanded hemodialysis therapy (HDx).
THERANOVA is an investigational device in the United States, and is not approved for commercial sale in that market. HDx enabled by THERANOVA is available in Canada and select European, Latin American and Asian markets.
Rx Only. For safe and proper use of AMIA, HOMECHOICE CLARIA with SHARESOURCE Remote Patient Management platform, refer to the appropriate Instructions for Use, Operation's Manual or User’s Guide.